<DOC>
	<DOCNO>NCT02311010</DOCNO>
	<brief_summary>To optimize Advagraf ( tacrolimus day ) initial daily dose use de novo kidney transplantation combination MMF ( MPA ) corticosteroid ( CS ) regard genetic Cyp 450 3A5 polymorphism recipient . The study tacrolimus level ( ng/ml ) determine therapeutic level reach .</brief_summary>
	<brief_title>Practical Use Advagraf de Novo After Kidney Transplantation According Recipient Genetic Polymorphism</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>First second Kidney Transplantation decease live donor Donor age &lt; 5 year . Patients require plasma exchange high immunological risk</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>transplant</keyword>
	<keyword>immunosuppressive drug</keyword>
</DOC>